Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers

IntroductionCongenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects that impact life and well-being.MethodsThe st...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Tai L. S. Pasquini, Kristen E. Rohli, Fiona J. Almeida, Indraneel Banerjee, Antonia Dastamani, Diva D. De Leon, Lauren N. Lopez, Paul S. Thornton, Julie Raskin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Subjects:	congenital hyperinsulinism hypoglycemia diazoxide rare diseases endocrinology natural history
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1628125/full